This is a preview of subscription content, log in via an institution to check access.
Notes
Costs were expressed in 2011 values.
Reference
Ito K, et al. Cost-effectiveness of full coverage of aromatase inhibitors for Medicare beneficiaries with early breast cancer. Cancer 119: 2494-2502, No. 13, Jul 2013. Available from: URL: http://dx.doi.org/10.1002/cncr.28084
Rights and permissions
About this article
Cite this article
Full coverage of AIs for early breast cancer saves cost. PharmacoEcon Outcomes News 682, 9 (2013). https://doi.org/10.1007/s40274-013-0547-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0547-7